Skip to main content

228 - References

References

Schizophrenia and related psychoses CHAPTER 1 References

  1. John AP, et al. Rates and reasons for clozapine treatment interruptions: impact of the frequency of hematologic monitoring and cardiac adverse events. J Clin Psychopharmacol 2023; 43:233–238.
  2. Shiovitz TM, et  al. Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawal. Schizophr Bull 1996; 22:591–595.
  3. Galova A, et al. A case report of cholinergic rebound syndrome following abrupt low-­dose clozapine discontinuation in a patient with type I bipolar affective disorder. BMC Psychiatry 2019; 19:73.
  4. Ahmed S, et al. Clozapine withdrawal-­emergent dystonias and dyskinesias: a case series. J Clin Psychiatry 1998; 59:472–477.
  5. Shrivastava M, et al. Relapse of tardive dyskinesia due to reduction in clozapine dose. Indian J Pharmacol 2009; 41:201–202.
  6. Boazak M, et al. Catatonia due to clozapine withdrawal: a case report and literature review. Psychosomatics 2019; 60:421–427.
  7. Lander M, et al. Review of withdrawal catatonia: what does this reveal about clozapine? Transl Psychiatry 2018; 8:139.
  8. Flanagan RJ, et al. Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals. Br Med Bull 2020; 135:73–89.
  9. de Leon J, et al. An international adult guideline for making clozapine titration safer by using six ancestry-­based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry 2022; 55:73–86.
  10. Gee SH, et al. Patient attitudes to clozapine initiation. Int Clin Psychopharmacol 2017; 32:337–342.
  11. Schulte PF, et  al. Comment on ‘effectiveness and safety of rapid clozapine titration in schizophrenia’. Acta Psychiatr Scand 2014; 130:69–70.
  12. Correll CU, et al. A guideline and checklist for initiating and managing clozapine treatment in patients with treatment-­resistant schizophrenia. CNS Drugs 2022; 36:659–679.
  13. National Association of Boards of Pharmacy (NABP). ISMP: Restarting clozapine too rapidly can cause severe cardiovascular effects. 2022 (last accessed February 2025); https://nabp.pharmacy/news/blog/regulatory_news/ismp-­restarting-­clozapine-­too-­rapidly-­can-­cause-­severe-­ cardiovascular-­effects.
  14. Shastay A. Caution when restarting clozapine. Home Healthc Now 2022; 40:54–55.
  15. Rubio JM, et al. How and when to use clozapine. Acta Psychiatr Scand 2020; 141:178–189.

No comments to display

Back to top